Drug Shortage Report for OLMETEC PLUS
Report ID | 80241 |
Drug Identification Number | 02319624 |
Brand name | OLMETEC PLUS |
Common or Proper name | Olmesartan medoxomil and hydrochlorothiazide tablets |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL |
Strength(s) | 12.5MG 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-05-10 |
Actual start date | 2019-04-18 |
Estimated end date | 2019-11-01 |
Actual end date | 2019-10-31 |
Shortage status | Resolved |
Updated date | 2019-11-01 |
Company comments | Back orders were partially released on October 17th |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.